Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYF-8: Cytotoxicity of YF-17D Vaccine
NCT04083430Phase 4Active, not recruiting
- Sponsor
- Aarhus University
- Start
- Oct 2019
- Primary completion
- Feb 2025
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 17D yellow fever vaccine in yellow fever, sponsored by Aarhus University. Started Oct 2019; status: active, not recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT04083430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04083430.